Jul 1, 2006
Overview
The University of Washington Program in Hematology and Medical Oncology offers a comprehensive curriculum designed to prepare trainees for a successful career in the field of oncology. This program is affiliated with the renowned Fred Hutchinson Cancer Center, recognized as a National Cancer Institute-designated center, providing trainees with unique opportunities to advance their clinical and research skills.
Curriculum Overview
The curriculum integrates clinical training, research participation, and didactic education, ensuring that residents gain a broad understanding of both hematology and oncology. The training involves structured rotations that cover various aspects of cancer care, including solid tumors, hematologic malignancies, palliative care, and supportive care. The program emphasizes multidisciplinary approaches and collaborative learning environments as trainees interact with specialists across various departments.Clinical Rotations
During the program, residents engage in a variety of clinical rotations that offer exposure to diverse patient populations and healthcare settings. Rotations include inpatient experiences, outpatient clinics, and specialty areas. Each rotation is designed to reinforce residents' diagnostic, management, and therapeutic skills while enhancing their understanding of the complexities of cancer treatment.Residents also participate in a continuity clinic, ensuring they develop long-term relationships with patients as their treatment progresses. This essential part of the training fosters excellent communication skills and patient-centered care practices.
Research Opportunities
Research is a cornerstone of the training program, with access to Fred Hutch’s extensive resources, including cutting-edge laboratories and innovative clinical trials. Residents are encouraged to identify research interests early on and work closely with faculty mentors to develop and complete research projects. Opportunities exist for residents to publish findings and present their work at national conferences, contributing to their professional development.Unique Aspects of the Program
This program stands out for its strong integration of clinical care and research, a hallmark of the UW Medicine and Fred Hutch collaboration. This unique relationship enables trainees to be at the forefront of translational research and evidence-based practice. Furthermore, the comprehensive support system from faculty, staff, and fellow residents promotes a collaborative and enriching educational environment.The program also encourages community involvement and outreach, providing opportunities to engage with patients outside of traditional clinical settings. This commitment to community service is integral to the program’s mission of improving health outcomes.
Training Sites
The primary training sites include UW Medical Center and Fred Hutchinson Cancer Center, which offers state-of-the-art facilities and access to advanced treatment modalities. Trainees rotate through multiple locations, gaining variety in their training experiences, which prepares them for diverse practice settings upon graduation.Visa Support
The program provides visa sponsorship opportunities for qualified international applicants, ensuring a supportive pathway for those seeking to further their training in the United States. Common visa types that the program sponsors include the J-1 visa for educational exchange and the H-1B visa for specialty occupations.Competitiveness and Requirements
The program is known to be highly competitive, attracting both U.S. medical graduates and international medical graduates (IMGs). Applicants should be aware of specific application requirements, including limitations on the number of failed STEP exams and considerations regarding graduation years. These criteria help ensure that the program maintains a standard of excellence among its applicants.To apply, candidates must demonstrate a commitment to hematology and oncology, as well as a strong academic record. A history of research involvement in oncology or related fields may provide an additional advantage in the selection process.
Web sources
SmartPick
Program data
ACGME History
Program
Program Size
-- (3 years)
Accreditation Status
Continued Accreditation
(Effective: January 23, 2026)
Composition
--
Training
Faculty-to-Residents Ratio:--
Quality of Life
First Year Paid Sick Leave: --
First Year Paid Vacation: --
First Year Salary: --
Admission
Visa Sponsorship:--
YOG Cutoff:--
Gender
No gender data available.
Rotation Duration by Site
Benchmarks
Roster
Publications
50 Publications (5 yr)
Peer-reviewed output from faculty and residents, last 5 years
50 Publications (5 yr)
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.
Factors associated with aggregate formation in cold-stored platelets.
Location
Seattle, WA
- Above the national average
- Below the national average
- Similar to the national average
Housing — Rental prices
Rental prices
Crime — All violent offences
Rate per 100,000 residents
Ready to Find Your Ideal Residency Program?
Get a personalized, data-driven program list built around your scores, experiences, and visa needs.
Nearby programs
Hematology and medical oncology Programs Near Seattle, WA
Other specialties near Seattle, WA
Write or evaluate your personal statement
External Links
1. United States Census Bureau - https://data.census.gov/profile/City,_VS?g=160XX00US5363000
2. Zillow Research - Observed Rent Index (ZORI) - https://www.zillow.com/research/data/
3. FBI - Crime/Law Enforcement Stats (Uniform Crime Reporting Program) - https://www.fbi.gov/services/cjis/ucr
See something inaccurate or missing? If you represent this program, request portal access to update it directly.